Glinz_2019_Swiss.Med.Wkly_149_w20093

Reference

Title : Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis - Glinz_2019_Swiss.Med.Wkly_149_w20093
Author(s) : Glinz D , Gloy VL , Monsch AU , Kressig RW , Patel C , McCord KA , Ademi Z , Tomonaga Y , Schwenkglenks M , Bucher HC , Raatz H
Ref : Swiss Med Wkly , 149 :w20093 , 2019
Abstract : Glinz_2019_Swiss.Med.Wkly_149_w20093
ESTHER : Glinz_2019_Swiss.Med.Wkly_149_w20093
PubMedSearch : Glinz_2019_Swiss.Med.Wkly_149_w20093
PubMedID: 31269225

Related information

Citations formats

Glinz D, Gloy VL, Monsch AU, Kressig RW, Patel C, McCord KA, Ademi Z, Tomonaga Y, Schwenkglenks M, Bucher HC, Raatz H (2019)
Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis
Swiss Med Wkly 149 :w20093

Glinz D, Gloy VL, Monsch AU, Kressig RW, Patel C, McCord KA, Ademi Z, Tomonaga Y, Schwenkglenks M, Bucher HC, Raatz H (2019)
Swiss Med Wkly 149 :w20093